Centre Europeen d'Etude du Diabete
Quick facts
Marketed products
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre Europeen d'Etude du Diabete portfolio CI brief
- Centre Europeen d'Etude du Diabete pipeline updates RSS
Frequently asked questions about Centre Europeen d'Etude du Diabete
What are Centre Europeen d'Etude du Diabete's marketed drugs?
Top marketed products include Basal-bolus detemir-aspart insulin regimen.